GLP-1 Weight-Management Medicines in the UK: Patient Information (2026)
Patient information about the GLP-1 receptor agonists used for weight management or type 2 diabetes in the UK — Mounjaro, Wegovy, Ozempic, Rybelsus, Nevolat. No prescription-medicine prices.
Important context
Healthcare prices can change without notice and may exclude consultation fees, medication, diagnostics, anaesthetic, facility fees, follow-up care or add-ons. TreatCompare summarises published or compiled pricing for comparison and planning only. Always verify the current total directly before paying.
- Source type
- TreatCompare compiled research
- Primary source
- Provider-published information and TreatCompare research
- Reporting period
- 2026-05-12
- Last updated
- 2026-05-12
- Figure type
- Mixed sources
- Use
- Research and comparison only
Are you a clinic, provider or data owner?
If you believe information on this page is inaccurate, out of date, incomplete or presented without necessary context, contact us with the page URL and supporting evidence. We review correction requests promptly, but they are not automatically accepted.
How this guide was checked
TreatCompare uses published provider fees, official regulator registers, NHS/PBS/Medicare references where relevant, and the methodology described on our methodology page. If a clinic, provider or reader spots information that is out of date, they can use our corrections page. Prices are point-in-time and can change before booking.
Most useful next step
Compare current Weight Loss options
This guide explains the UK service-cost framework. Continue to provider checks, NHS eligibility and medicine patient information without public prescription-medicine prices.
Continue from this guide
Turn this Weight Loss article into a comparison
Article visitors often need one of three routes next: provider checks, NHS eligibility, or a related medicine information page.
Important information for UK consumers. The medicines covered in this article are prescription-only medicines (POMs) in the UK. UK regulations restrict the advertising of prescription medicines to the public, so this article is general patient information — it is not an advertisement, not an offer of sale, and not medical advice. This article does not display UK prices for any of the medicines mentioned.
GLP-1 medicines used in the UK
| Brand (active ingredient) | Manufacturer | UK indication | Administration |
|---|---|---|---|
| Mounjaro (tirzepatide) | Eli Lilly | Weight management; separately licensed for type 2 diabetes | Weekly subcutaneous injection |
| Wegovy (semaglutide 2.4mg) | Novo Nordisk | Weight management | Weekly subcutaneous injection |
| Ozempic (semaglutide) | Novo Nordisk | Type 2 diabetes (off-label use for weight management is a clinical decision) | Weekly subcutaneous injection |
| Rybelsus (oral semaglutide) | Novo Nordisk | Type 2 diabetes | Daily oral tablet |
| Nevolat (liraglutide) | Zentiva | Weight management (the generic equivalent of the discontinued Saxenda) | Daily subcutaneous injection |
Tirzepatide is the only dual GIP/GLP-1 receptor agonist in this group. The others act on the GLP-1 receptor only.
NICE / NHS context
- Tirzepatide for weight management: NICE TA1026, with a phased NHS rollout decided by NHS England commissioning policy.
- Semaglutide 2.4mg for weight management: NICE TA875, NHS access via Tier 3 specialist services after GP referral.
- Ozempic, Rybelsus and Nevolat: prescribed within their licensed indications under current NICE guidance and local commissioning rules.
Service-level costs
For UK private weight-management consultations, see the service-cost framework. The medicine itself is priced separately by the dispensing GPhC-registered pharmacy and is not displayed on TreatCompare’s consumer pages.
What to discuss with a UK prescriber
- Which medicine is licensed for your clinical question.
- Whether NHS-funded treatment is realistic before paying privately.
- The dose escalation schedule and tolerability monitoring approach.
- Common and serious side effects, and what to do if they occur.
For individual patient-information pages see Mounjaro, Wegovy, Ozempic, Rybelsus and Nevolat.
If you have spotted an error
Please tell us via the corrections route.
Data funnel
Help improve UK healthcare price data
TreatCompare gets more useful when readers send real quotes, providers verify listings, and outdated claims are corrected. Submissions are reviewed before publication.
Frequently asked questions
What is a GLP-1 receptor agonist?
GLP-1 (glucagon-like peptide-1) receptor agonists are medicines that mimic the GLP-1 hormone, which is involved in regulating blood glucose, appetite and gastric emptying. They are licensed for type 2 diabetes and, in higher-dose formulations, for weight management.
Why does this article not show UK prices?
GLP-1 weight-management medicines are prescription-only medicines (POMs) in the UK. UK Human Medicines Regulations 2012 prohibit advertising POMs to the public, including price comparisons. TreatCompare does not display UK GLP-1 prices on consumer pages.
How are GLP-1 medicines accessed on the NHS?
NHS access is decided by NICE technology appraisals and NHS England commissioning policy. Tirzepatide (Mounjaro) is recommended under TA1026 with a cohort rollout. Semaglutide 2.4mg (Wegovy) is recommended under TA875 via Tier 3 specialist services. Speak to your GP for local availability.
Continue with UK weight-loss cost guidance
Weight Loss Injection Cost UK
Service-cost framework, NHS eligibility, provider checks and patient information for Mounjaro, Wegovy, Ozempic and Nevolat queries.
Lower-Cost Injection Route
NHS access, service fees and provider checks
Mounjaro Price UK Questions
Service fees, NHS access and provider checks
Wegovy Price UK Questions
Service fees, NHS access and dose context
Mounjaro Patient Information
Tirzepatide doses, safety checks and prescriber questions
Wegovy Patient Information
Semaglutide 2.4mg doses, safety checks and NHS route
Related articles
Who Should Not Take Mounjaro or Wegovy? A GP's Guide
A UK GP's guide to who should not take Mounjaro (tirzepatide) or Wegovy (semaglutide), who needs extra caution, and the red-flag symptoms that need urgent medical help. Patient information, not medical advice.
Lower-Cost Weight Loss Injections UK 2026: NHS Access, Service Fees and Provider Checks
Lower-cost weight loss injections UK guide: how to compare private consultation service fees, NHS eligibility, follow-up costs and provider safety checks without public prescription-medicine price tables.
How to Get Mounjaro in the UK: Patient Information (2026)
Patient information about UK NHS and private routes for Mounjaro (tirzepatide). Not an advertisement and not medical advice.
Mounjaro Price UK 2026: Cost Questions, NHS Access and Provider Checks
Mounjaro price UK guide: why prescription-medicine prices are not displayed, what private service fees to ask about, NHS access and GPhC provider checks.